[阿波啡辅助治疗特发性帕金森综合征]。

Swiss Archives of Neurology and Psychiatry Pub Date : 1994-01-01

M F Bösch, H P Ludin

{"title":"[阿波啡辅助治疗特发性帕金森综合征]。","authors":"M F Bösch, H P Ludin","doi":"","DOIUrl":null,"url":null,"abstract":"28 patients suffering from idiopathic Parkinson's disease received subcutaneous apomorphine for the treatment of painful dystonia and of off-phases of long duration. After a mean period of 12.4 months 20 patients still used apomorphine. In this time the mean dose per injection had fallen from 2.5 mg to 2.1 mg and the mean number of daily applications from 2.6 to 2.2. Most patients considered dystonias and off-phases to respond satisfactorily to apomorphine. However, in most cases the treatment effect was impaired by side effects, especially nausea.","PeriodicalId":30134,"journal":{"name":"Swiss Archives of Neurology and Psychiatry","volume":"145 5","pages":"8-13"},"PeriodicalIF":0.0000,"publicationDate":"1994-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Apomorphine as adjuvant treatment in idiopathic Parkinson syndrome].\",\"authors\":\"M F Bösch, H P Ludin\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"28 patients suffering from idiopathic Parkinson's disease received subcutaneous apomorphine for the treatment of painful dystonia and of off-phases of long duration. After a mean period of 12.4 months 20 patients still used apomorphine. In this time the mean dose per injection had fallen from 2.5 mg to 2.1 mg and the mean number of daily applications from 2.6 to 2.2. Most patients considered dystonias and off-phases to respond satisfactorily to apomorphine. However, in most cases the treatment effect was impaired by side effects, especially nausea.\",\"PeriodicalId\":30134,\"journal\":{\"name\":\"Swiss Archives of Neurology and Psychiatry\",\"volume\":\"145 5\",\"pages\":\"8-13\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1994-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Swiss Archives of Neurology and Psychiatry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Swiss Archives of Neurology and Psychiatry","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

28例特发性帕金森氏病患者接受皮下阿波啡治疗疼痛性肌张力障碍和长时间非期。平均12.4个月后，20名患者仍在使用阿扑吗啡。在此期间，每次注射的平均剂量从2.5毫克下降到2.1毫克，平均每日使用次数从2.6毫克下降到2.2毫克。大多数患者认为肌张力障碍和非期对阿波啡的反应令人满意。然而，在大多数情况下，治疗效果受到副作用的影响，特别是恶心。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

[Apomorphine as adjuvant treatment in idiopathic Parkinson syndrome].

28 patients suffering from idiopathic Parkinson's disease received subcutaneous apomorphine for the treatment of painful dystonia and of off-phases of long duration. After a mean period of 12.4 months 20 patients still used apomorphine. In this time the mean dose per injection had fallen from 2.5 mg to 2.1 mg and the mean number of daily applications from 2.6 to 2.2. Most patients considered dystonias and off-phases to respond satisfactorily to apomorphine. However, in most cases the treatment effect was impaired by side effects, especially nausea.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Swiss Archives of Neurology and Psychiatry

自引率

0.00%

发文量

审稿时长

16 weeks

期刊介绍： Schweizer Archiv für Neurologie und Psychiatrie Archives suisses de neu-rologie et de psychiatrie Swiss Archives of Neurology and Psychiatry Official publication of the Swiss Neurological Society and official scientific publication of the Swiss Society of Psychiatry and Psychotherapy and the Swiss Society for Child and Adolescent Psychiatry and Psychotherapy